Decreases in plasma adiponectin levels are observed in cardiovascular disease, essential hypertension, obesity and type II diabetes8, 9, 10, which may suggest a special role of adiponectin in the pathogenesis of hypertension. This evidence concerns the gene ADIPOQ and essential hypertension.